Antineutrophil cytoplasmic autoantibodies and anti-Saccharomyces cerevisiae antibodies in inflammatory bowel diseases

Turkish Journal of Gastroenterology

Volumn 15, Issue 4, 2004, Pages 238-242

  Kiliç, Z Mesut Yalin ^a   Tunç, Bilge ^a   Ayaz, Selime ^a   Filik, Levent ^a,b   Aktaş, Semra ^a   Parlak, Erkan ^a   Ülker, Aysel ^a  

^a TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

^b Department of Hematology ^*  (Turkey)

Author keywords

Anti Saccharomyces cerevisiae antibody; Antineutrophil cytoplasmic autoantibody; Crohn's disease; Ulcerative colitis

Indexed keywords

AUTOANTIBODY; FUNGUS ANTIBODY; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; SACCHAROMYCES CEREVISIAE; SEROLOGY; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIBODIES, FUNGAL; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SACCHAROMYCES CEREVISIAE; TURKEY;

EID: 13244267172     PISSN: 13004948     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Lee KS, Medline A, Shockey S. Indeterminate colitis in the spectrum of inflammatory bowel disease. Arch Pathol Lab Med 1979; 103: 173-6.
2. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol 1989; 24(Suppl): 2-6.
3. Price AB. Overlap in the spectrum of non-specific inflammatory bowel disease-"colitis indeterminate". J Clin Pathol 1978; 31: 567-77.
4. Hamilton SR. The differential diagnosis of idiopathic inflammatory bowel disease by colorectal biopsy. Int J Colorectal Dis 1987; 2: 113-7.
5. Giaffer MH, Clark A, Holdsworth CD. Antibodies to selected strains of Saccharomyces cerevisiae (baker's and brewer's yeast) and Candida albicans in Crohn's disease. Gut 1990; 31: 536-8.
6. Pokorny CS, Norton ID, McCaughan GW, et al. Anti-neutrophil cytoplasmic antibody: a prognostic indicator in primary sclerosing cholangitis. J Gastroenterol Hepatol 1994; 9: 40-4.
7. Rutgeerts P, Vermeire S. Clinical value of detection of antibodies in the serum for diagnosis and treatment of inflammatory bowel disease. Gastroenterology 1998; 115: 1006-9.
8. Arslan S, Akcan Y, Bakkaloǧlu A, et al. The significance of p-ANCA in differing chronic amebic colitis from ulcerative colitis complicated with amebic colitis. Turk J Gastroenterol 2000; 11(1): 39-44.
9. Bernstein CN, Orr K, Blanchard JF, et al. Development of an assay for antibodies to Saccharomyces cerevisiae: easy, cheap and specific for Crohn's disease. Can J Gastroenterol 2001; 15(8): 499-504.
10. Quinton JF, Sendid B, Reumax D, et al. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut 1998; 42: 788-91.
11. Koutrobakis IE, Petinaki E, Mouzas IA, et al. Anti-Saccharomyces cerevisiae Mannan antibodies and antineutrophil cytoplasmic autoantibodies in Greek patients with inflammatory bowel disease. Am J Gastroenterol 2001; 96(2): 449-54.
12. Moore MM, Fabricatorian D, Selby WS. Assessment and relevance of enzyme-linked immunosorbent assay for antibodies to Saccharomyces cerevisiae in Australian patients with inflammatory bowel disease. Int Med J 2002; 32: 349-52.
13. Peeters M, Joossens S, Vermeire S, et al. Am J Gastroenterol 2001; 96(3): 730-4.
14. Halme L, Turunen U, Helio T, et al. Familial and sporadic inflammatory bowel disease. Scand J Gastroenteol 2002; 6: 692-8.
15. Hoffenberg EJ, Fidanza S, Sauaia A. Serologic testing for inflammatory bowel disease. J Pediatrics 1999; 134(4): 447-52.
16. Vasiliauskas EA, Plevy SE, Landers CJ, et al. Perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn's disease define a clinical group. Gastroenterology 1996; 112(1): 316-7.
17. Targan SR. The utility of ANCA and ASCA in inflammatory bowel disease. Inflammatory Bowel Disease 1999; 5(1): 61-3.
18. Vermeire S, Peeters M, Vlietnick R, et al. Anti-Saccharomyces cerevisiae antibodies (ASCA), phenotypes of IBD, and intestinal permeability: a study in IBD families. Inflamm Bowel Dis 2001; 7(1): 8-15.